UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
October 16, 2003
Date of report (Date of earliest event reported)
CIMA LABS INC.
(Exact Name of Registrant as Specified in its Charter)| | | | | |
| Delaware | | 0-24424 | | 41-1569769 |
| |
| |
|
| (State of Incorporation) | | (Commission File Number) | | (I.R.S. Employer
Identification No.) |
10000 Valley View Road
Eden Prairie, Minnesota | | | | 55344-9361 |
| | | |
|
(Address of Principal
Executive Offices) | | | | (Zip Code) |
(952) 947-8700
(Registrant’s Telephone Number, Including Area Code)
TABLE OF CONTENTS
Item 5. Other Events.
On October 16, 2003, CIMA LABS INC., a Delaware corporation (“CIMA”) issued a press release announcing that it received an unsolicited letter from a publicly held pharmaceutical company indicating an interest in pursuing a business combination with CIMA. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7(c). Exhibits.
See Exhibit Index.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 16, 2003
| | | | | |
| | | CIMA LABS INC. |
| | | | | |
| | | By: | | /s/ JAMES C. HAWLEY |
| | | | |
|
| | | | | James C. Hawley
Vice President, Chief Financial
Officer and Secretary |
Exhibit Index
| | | | | |
| Exhibit No. | | Description | | Method of Filing |
| |
| |
|
| 99.1 | | Press Release dated October 16, 2003. | | Filed herewith |
